
Predictive Genetic Testing and Consumer Wellness Genomics Market Share
Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screen...

Market Summary
Key Market Trends & Highlights
Market Trends
Predictive Genetic Testing and Consumer Wellness Genomics Market Market Drivers
Market Segment Insights
Regional Insights
Industry Developments
- In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
- In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
- In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
- In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
- In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
Market Segmentation
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
By Test Type
- Predictive Testing
- Consumer Genomics
- Wellness Genomics
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
By Setting Type
- Proteomic Testing
- Metabolic Testing
- Genomic Testing
Rest of the World
- Middle East
- Africa
- Latin America
By Application type
- Breast & Ovarian Cancer
- Cardiovascular Screening
- Colon Cancer
- Others
List of companies covered in this report:
- 23andMe, Inc. (California)
- Myriad Genetics, Inc. (US)
- Hoffmann-La Roche Ltd. (Switzerland)
- Abbott Laboratories (US)
- Genesis Genetics (US)
- Agilent Technologies (US)
- Thermo Fisher Scientific, Inc. (US)
- Bureau Gravimétrique International (China)
- Bio-Rad Laboratories Inc. (US)
- Illumina, Inc. (US)
- Counsyl, Inc. (California)
- ARUP Laboratories (US)
- Others
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments
- In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
- In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
- In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
- In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
- In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type
- Wellness Genomics
- Nutria Genetic
- Skin & Metabolism Genetics
- Others
- Consumer Genomics
- Predictive Testing
- Genetic Susceptibility Test
- Predictive Diagnostic
- Population Screening
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application
- Breast & Ovarian Cancer
- Cardiovascular Screening
- Diabetic Screening & Monitoring
- Colon Cancer
- Parkinsonism/Alzheimer’s Disease
- Urologic Screening/Prostate Cancer Screening
- Orthopedic & Musculoskeletal
- Others
Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type
- Proteomic Testing
- Metabolic Testing
- Genomic Testing
Report Scope
Report Attribute/Metric | Details |
Market Size | USD 11.2 Billion |
CAGR | 5.4% |
Base Year | 2022 |
Forecast Period | 2023-2032 |
Historical Data | 2021 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Test Type, Application, and Setting Type |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World |
Key Vendors | 23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) |
Key Market Opportunities | Rise of application in personalized medicine |
Key Market Drivers | Usage of predictive genetic testing & consumer/wellness genomics in various applications |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?
The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)
Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?
23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.
Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?
North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics
What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?
Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.
Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?
High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics
-
Table of Contents
-
Executive Summary
-
Market Introduction
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
-
Research Methodology
- Overview
- Data Mining
- Secondary Research
-
Primary Research
- Primary Interviews and Information Gathering Process
- Breakdown of Primary Respondents
- Forecasting Application
-
Market Size Estimation
- Bottom-up Approach
- Top-Down Approach
- Data Triangulation
- Validation
-
MARKET DYNAMICS
- Overview
- Drivers
- Restraints
- Opportunities
-
MARKET FACTOR ANALYSIS
-
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
-
COVID-19 Impact Analysis
- Market Impact Analysis
- Impact on Supply Chain
- Regional Impact
- Opportunity and Threat Analysis
-
Porter’s Five Forces Analysis
-
GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE
- Overview
-
Predictive Testing
- Genetic Susceptibility Test
- Predictive Diagnostic
- Population Screening
- Consumer Genomics
-
Wellness Genomics
- Nutria Genetic
- Skin & Metabolism Genetics
- Others
-
GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
- Overview
- Breast & Ovarian Cancer
- Cardiovascular Screening
- Diabetic Screening & Monitoring
- Colon Cancer
- Parkinsonism/Alzheimer’s Disease
- Urologic Screening/Prostate Cancer Screening
- Orthopedic & Musculoskeletal
- Others
-
GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
- Overview
- Proteomic Testing
- Metabolic Testing
- Genomic Testing
-
GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
- Overview
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
-
Rest of the World
- Middle East
- Africa
- Latin America
-
COMPANY LANDSCAPE
- Overview
- Competitive Analysis
- Market Share Analysis
- Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness Genomics Market
- Competitive Benchmarking
- Leading Players in Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness Genomics Market
-
Key developments and Growth Strategies
- New Product Launch/Service Deployment
- Merger & Acquisitions
- Joint Ventures
-
Major Players
- Sales & Operating Income, 2020
- Major Players R&D Expenditure. 2020
-
COMPANY PROFILES
-
23andMe, Inc.
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
- Myriad Genetics, Inc.
- F.Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Genesis Genetics
- Agilent Technologies
- Thermo Fisher Scientific, Inc.
- Bureau Gravimétrique International
- Bio-Rad Laboratories Inc.
- Illumina, Inc.
- Counsyl, Inc.
- ARUP Laboratories
- Others
-
23andMe, Inc.
-
APPENDIX
- References
- Related Reports
-
List of Tables and Figures
- LIST OF TABLES
- TABLE 1 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SYNOPSIS, 2023–2032
- TABLE 2 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2023–2032 (USD MILLION)
- TABLE 3 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 6 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 7 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 9 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 10 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 11 US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 12 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 13 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 14 CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 15 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 1 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 2 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 3 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 4 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 5 GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 6 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 7 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 8 FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 9 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 10 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 11 ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 12 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 13 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 14 SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 15 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 16 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 17 UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 18 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 19 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 20 REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 21 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 22 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 23 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 24 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 25 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 26 JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 27 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 28 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 29 CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 30 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 31 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 32 INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 33 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 34 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 35 AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 36 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 37 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 38 SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 39 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 40 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 41 REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 42 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 43 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 44 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 45 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 46 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 47 MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 48 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 49 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 50 AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
- TABLE 51 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
- TABLE 52 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
- TABLE 53 LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION) LIST OF FIGURES
- FIGURE 1 RESEARCH PROCESS
- FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET
- FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET
- FIGURE 4 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020 (%)
- FIGURE 5 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY APPLICATION, 2020 (%)
- FIGURE 6 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%)
- FIGURE 7 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
- FIGURE 8 NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
- FIGURE 9 EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
- FIGURE 10 ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
- FIGURE 11 REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
- FIGURE 12 GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
- FIGURE 13 23ANDME, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 14 23ANDME, INC.: SWOT ANALYSIS
- FIGURE 15 MYRIAD GENETICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 16 MYRIAD GENETICS INC.: SWOT ANALYSIS
- FIGURE 17 F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 18 F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
- FIGURE 19 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 20 ABBOTT LABORATORIES: SWOT ANALYSIS
- FIGURE 21 GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 22 GENESIS GENETICS: SWOT ANALYSIS
- FIGURE 23 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 24 AGILENT TECHNOLOGIES: SWOT ANALYSIS
- FIGURE 25 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
- FIGURE 27 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 28 BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT ANALYSIS
- FIGURE 29 BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 30 BIO-RAD LABORATORIES INC..: SWOT ANALYSIS
- FIGURE 31 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 32 ILLUMINA, INC.: SWOT ANALYSIS
- FIGURE 33 COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 34 COUNSYL, INC.: SWOT ANALYSIS
- FIGURE 35 ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 36 ARUP LABORATORIES: SWOT ANALYSIS
Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation
Market Segmentation Overview
- Detailed segmentation data will be available in the full report
- Comprehensive analysis by multiple parameters
- Regional and country-level breakdowns
- Market size forecasts by segment

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment